A new study in the Journal of the National Cancer Institute JNCI) says there is an increase in incidences of cancer associated with human papillomavirus (HPV) infection.
As reported in Science Daily, the national cancer rates are going down, JNCI notes, but researchers hope that the study will encourage more women and men to get HPV vaccinations.
HPV vaccination efforts may be focused on females “because it’s been predicted to be the most effective way to ensure population-level vaccine effectiveness,” says Marc Brisson, Ph.D., and colleagues in an editorial that accompanies the study, the site adds. But according to research that emerged in 2011, half of men in the general population may be infected with HPV and spreading it.
HPV is a human wart virus primarily known as the leading cause of cervical cancer, the second most common cancer in women worldwide, The Huffington Post reports.
But strains of the virus also cause anal, penile, head and neck cancers. Anna Giuliano, of the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, and colleagues found that about 50% of men have genital HPV infections, similar to women biologically but harder to clear, the Post published.
The site also noted that Dr. Anne Szarewski of the Wolfson Institute of Preventive Medicine in London claimed that high HPV infection rates in men “emphasize their role in transmission of HPV to women.”
HLN’s Dr. Drew added, “We have a cancer-preventative vaccine. There’s nothing else like it. Tens of thousands of deaths can be prevented. It’s silly not to get it.”
Those with concerns should consult their physician.